Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Health Catalyst, Inc.

Health Catalyst, Inc. (HCAT) Stock Overview

Explore Health Catalyst, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HCAT●NASDAQ
HealthcareMedical - Healthcare Information Services
$2.08
$0.07(3.48%)
U.S. Market opens in 63h 27m

Health Catalyst, Inc. (HCAT)

Meyka AI Score

Z

Key Financials

Market Cap153.7M
P/E Ratio-0.56
EPS (TTM)$0.20
ROE-1.00%
Fundamental Analysis

AI Price Forecasts

1 Month$1.15
3 Months$3.02
1 Year Target$0.00

HCAT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Health Catalyst, Inc. (NASDAQ: HCAT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Health Catalyst, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HCAT on the NASDAQ shows an RSI of 52.57, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Health Catalyst, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.56 and a market capitalization of 153.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HCAT on the NASDAQ.

Price Performance (NASDAQ: HCAT)

1-Day Change
3.48%
5-Day Change
-10.34%
1-Month Change
20.93%
3-Month Change
50.72%
6-Month Change
-7.56%
Year-to-Date (YTD) Change
-12.97%
1-Year Change
-45.97%
3-Year Change
-83.69%
5-Year Change
-96.28%
All-Time (Max) Change
-94.69%

Contact Information

https://www.healthcatalyst.com
801 708 6800
10897 South River Front Parkway, South Jordan, UT, 84095

Company Facts

12,000 Employees
IPO DateJul 25, 2019
CountryUS
Actively Trading

Frequently Asked Questions